Literature DB >> 20303325

Simplified method for the chemical diagnosis of organic aciduria using GC/MS.

Katsuhiro Nakagawa1, Shuichi Kawana, Yuki Hasegawa, Seiji Yamaguchi.   

Abstract

GC/MS is widely used for the analysis of urinary organic acids for the chemical diagnosis of organic acidurias such as methylmalonic acidemia, propionic acidemia, isovaleric acidemia, glutaric aciduria type I, and multiple carboxylase deficiency. In this study, a rapid and simple preparation method for this analysis was developed in order to improve the laboratory productivity and the working environment. The solvent extraction and trimethylsilyl derivatization steps of the conventional method were improved by reducing the volume of urine sample and extraction solvent and by applying the flash-heater derivatization, respectively. The new method was successfully applied to the chemical diagnoses of five organic acidurias. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303325     DOI: 10.1016/j.jchromb.2010.02.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Clinical characteristics and gene mutation analysis of methylmalonic aciduria.

Authors:  Qin Yi; Juanjuan Lv; Fengyan Tian; Hong Wei; Qin Ning; Xiaoping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

2.  Fast and accurate quantitative organic acid analysis with LC-QTOF/MS facilitates screening of patients for inborn errors of metabolism.

Authors:  Irene M L W Körver-Keularts; Ping Wang; Huub W A H Waterval; Leo A J Kluijtmans; Ron A Wevers; Claus-Dieter Langhans; Camilla Scott; Daphna D J Habets; Jörgen Bierau
Journal:  J Inherit Metab Dis       Date:  2018-02-12       Impact factor: 4.982

3.  Screening of inherited metabolic abnormalities in 56 children with intractable epilepsy.

Authors:  Xiaoming Liu; Rui Li; Shengzhi Chen; Yan Sang; Jiaqiang Zhao
Journal:  Exp Ther Med       Date:  2016-04-15       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.